Purpose Assessment of individual VTE risk in cancer patients prior to chemotherapy is
critical for determining necessity of interventions. Risk assessment models (RAM) are …

Background: Modern oncology has a compelling problem in predicting the hazards of
venous thromboembolism (VTE) linked with chemotherapy. Although thromboprophylaxis is …

The risk of venous thromboembolism (VTE) is increased in cancer patients. To improve
prediction of VTE in cancer patients, we performed a prospective and observational cohort …

In ambulatory patients with solid cancer, routine thromboprophylaxis to prevent venous
thromboembolism is not recommended. Several risk prediction scores to identify cancer …

Background Current risk assessment models (RAMs) for prediction of venous
thromboembolism (VTE) risk in the outpatient cancer population have shown poor predictive …

Background Oncology guidelines suggest using the Khorana score to select ambulatory
cancer patients receiving chemotherapy for primary venous thromboembolism (VTE) …

Cancer patients with venous thromboembolism (VTE) are prone to poor prognoses. Thus,
we aimed to develop a nomogram to predict the risk of VTE in these patients. We …

Cancer patients are at higher risk for venous thromboembolism (VTE). Several risk
assessment models (RAM), including the Khorana and COMPASS-CAT, were developed to …

Abstract Background: Venous Thromboembolism (VTE) is a common complication of cancer
and is strongly associated with early all-cause mortality during the course of cancer …

Abstract Background The Khorana score is a validated tool to identify cancer patients at
higher risk of venous thromboembolism (VTE). Objective We compared its predictive …